FDA grants breakthrough status to Norroy kidney cancer imaging agent
Biotechnology firm Norroy Bioscience secured Breakthrough Therapy and Fast Track designations from the US FDA on 19 August 2026 for its kidney cancer imaging product
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.